tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
West Pharmaceutical price target lowered to $340 from $355 at UBS
PremiumThe FlyWest Pharmaceutical price target lowered to $340 from $355 at UBS
1M ago
West Pharmaceutical price target raised to $315 from $310 at Deutsche Bank
Premium
The Fly
West Pharmaceutical price target raised to $315 from $310 at Deutsche Bank
1M ago
West Pharmaceutical price target lowered to $265 from $325 at Barclays
Premium
The Fly
West Pharmaceutical price target lowered to $265 from $325 at Barclays
1M ago
West Pharmaceutical sees Q1 adjusted EPS $1.65-$1.70, consensus $1.65
PremiumThe FlyWest Pharmaceutical sees Q1 adjusted EPS $1.65-$1.70, consensus $1.65
1M ago
West Pharmaceutical sees FY26 adjusted EPS $7.85-$8.20, consensus $7.76
Premium
The Fly
West Pharmaceutical sees FY26 adjusted EPS $7.85-$8.20, consensus $7.76
1M ago
West Pharmaceutical reports Q4 adjusted EPS $2.04, consensus $1.83
Premium
The Fly
West Pharmaceutical reports Q4 adjusted EPS $2.04, consensus $1.83
1M ago
West Pharmaceutical: SmartDose Divestiture Clarifies Strategy and Enhances Margin Outlook, Supporting Buy Rating
PremiumRatingsWest Pharmaceutical: SmartDose Divestiture Clarifies Strategy and Enhances Margin Outlook, Supporting Buy Rating
2M ago
West Pharmaceutical to sell SmartDose 3.5mL rights to AbbVie for $112.5M
Premium
The Fly
West Pharmaceutical to sell SmartDose 3.5mL rights to AbbVie for $112.5M
2M ago
AbbVie to acquire Arizona manufacturing facility, IP from West Pharmaceutical
Premium
The Fly
AbbVie to acquire Arizona manufacturing facility, IP from West Pharmaceutical
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100